These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32588899)

  • 21. Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    Minchole E; Figueredo AL; Omeñaca M; Panadero C; Royo L; Vengoechea JJ; Fandos S; de Pablo F; Bello S
    PLoS One; 2016; 11(11):e0165711. PubMed ID: 27832114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pandemic H1N1 and seasonal H3N2 influenza infection in the human population show different distributions of viral loads, which substantially affect the performance of rapid influenza tests.
    Yang JR; Lo J; Ho YL; Wu HS; Liu MT
    Virus Res; 2011 Jan; 155(1):163-7. PubMed ID: 20875469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Illness Severity in Hospitalized Influenza Patients by Virus Type and Subtype, Spain, 2010-2017.
    Delgado-Sanz C; Mazagatos-Ateca C; Oliva J; Gherasim A; Larrauri A
    Emerg Infect Dis; 2020 Feb; 26(2):220-228. PubMed ID: 31961295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between type-specific influenza circulation and incidence of severe laboratory-confirmed cases; which subtype is the most virulent?
    Lytras T; Andreopoulou A; Gkolfinopoulou K; Mouratidou E; Tsiodras S
    Clin Microbiol Infect; 2020 Jul; 26(7):922-927. PubMed ID: 31760112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.
    Hayward AC; Fragaszy EB; Bermingham A; Wang L; Copas A; Edmunds WJ; Ferguson N; Goonetilleke N; Harvey G; Kovar J; Lim MS; McMichael A; Millett ER; Nguyen-Van-Tam JS; Nazareth I; Pebody R; Tabassum F; Watson JM; Wurie FB; Johnson AM; Zambon M;
    Lancet Respir Med; 2014 Jun; 2(6):445-54. PubMed ID: 24717637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influenza surveillance results in 2007-2008 winter season in nine provinces of Turkey].
    Carhan A; Altaş AB; Albayrak N; Uyar Y
    Mikrobiyol Bul; 2009 Apr; 43(2):235-41. PubMed ID: 19621608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019-2020 A(H1N1)pdm09 predominant influenza season in Israel.
    Jurkowicz M; Nemet I; Atari N; Fratty IS; Kliker L; Sherbany H; Keller N; Leibovitz E; Mendelson E; Mandelboim M; Stein M
    J Med Virol; 2023 Feb; 95(2):e28498. PubMed ID: 36653733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    Gherasim A; Martínez-Baz I; Castilla J; Pozo F; Larrauri A;
    PLoS One; 2017; 12(6):e0179160. PubMed ID: 28614376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differing clinical characteristics between influenza strains among young healthy adults in the tropics.
    Yap J; Tan CH; Cook AR; Loh JP; Tambyah PA; Tan BH; Lee VJ
    BMC Infect Dis; 2012 Jan; 12():12. PubMed ID: 22264216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.
    Fowlkes A; Steffens A; Temte J; Lonardo SD; McHugh L; Martin K; Rubino H; Feist M; Davis C; Selzer C; Lojo J; Oni O; Kurkjian K; Thomas A; Boulton R; Bryan N; Lynfield R; Biggerstaff M; Finelli L;
    Lancet Respir Med; 2015 Sep; 3(9):709-718. PubMed ID: 26300111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.
    Zhang L; Pan Y; Ma C; Duan W; Sun Y; Wu S; Zhang M; Tian Y; Zheng Y; Yang P; Wang Q
    Hum Vaccin Immunother; 2018 Jun; 14(6):1323-1330. PubMed ID: 29461909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False-positive PCR results linked to administration of seasonal influenza vaccine.
    Curran T; McCaughey C; Ellis J; Mitchell SJ; Feeney SA; Watt AP; Mitchell F; Fairley D; Crawford L; McKenna J; Coyle PV
    J Med Microbiol; 2012 Mar; 61(Pt 3):332-338. PubMed ID: 22096134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of epidemiology and clinical outcomes between influenza A H1N1pdm09 and H3N2 based on multicenter surveillance from 2014 to 2018 in South Korea.
    Yoon JG; Noh JY; Choi WS; Lee J; Lee JS; Wie SH; Kim YK; Jeong HW; Kim SW; Park KH; Song JY; Cheong HJ; Kim WJ
    Influenza Other Respir Viruses; 2021 Jan; 15(1):99-109. PubMed ID: 32844596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.